MedTrace Logo

Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia

NCT04171258 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-04-22

No results posted yet for this study

Summary

To determine the efficacy and safety of Botulax® in treatment of cervical dystonia

Conditions

  • Cervical Dystonia

Interventions

DRUG

Botulinum toxin type A injection

Experimental

DRUG

Botulinum Toxin Type A Injection [Botox]

Active Comparator

Sponsors & Collaborators

  • Hugel

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-26
Primary Completion
2021-04-26
Completion
2021-10-26

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171258 on ClinicalTrials.gov